phase readout
saveNCT07748000: A Study of LIQ861 (Inhaled Treprostinil) in Adults With Systemic Sclerosis Who Have Symptomatic Raynaud's Phenomenon Attacks
NOT_YET_RECRUITINGupdated 1d ago
community read0 votes
Sponsor: Liquidia Technologies, Inc.. Phase: PHASE2. Conditions: Raynaud's Phenomenon Secondary to Systemic Sclerosis
view source ↗
comments(0)
5-min edit window · permanent after that